GYRE
Gyre Therapeutics, Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 9:44:49 AM EST
4.62USD+6.452%(+0.28)75,481
GYRE Financials
In Q3 FY 2026 (ended ), Gyre Therapeutics, Inc. Common Stock (GYRE) reported revenue of $32.93M, net income of −$2.48M, operating cash flow of −$3.98M, and assets of $201.25M (filed ).
Loading business breakdowns…